Anthem Biosciences Ltd

Anthem Bioscienc | 544449

Market Closed

₹924.50

+₹31.44 (+3.52%)

As on 02/09/26, 1:23 AM

Market Cap52,069.54 CR

Current Price₹924.5

High / Low₹942.6 / 579.15

PE Ratio62.27

Book Value₹54.16

Dividend Yield0.30%

ROCE29.30%

ROE23.70%

Face Value₹2.00

Current Vol.13,26,412

Average Vol.---

ISININE0CZ201020

PB Ratio12.12

Debt to Equity0.03

Net Profit Margin27.86

Operating Margin45.44

ANTHEM - Share Price Chart

+₹0.00 (+0.00%)6M

Stock Performance

₹893.05₹893.2

₹924.5

Previous CloseToday's Open

₹579.15₹942.6

₹924.5

52W Low52W High

₹893.2Today's Open

₹893.05Previous Close

13,26,412Volume

₹579.1552W Low

₹942.652W High

Ratios

No data available

About Company

Anthem Biosciences Limited was originally incorporated as 'Anthem Biosciences Private Limited', dated June 13, 2006, issued by RoC
Subsequently, Company was converted from a Private Company to a Public Company , followed by the change in name of the Company to 'Anthem Biosciences Limited' and a Certificate of Incorporation was issued by RoC on December 10, 2024
The Company has been set up as a Life sciences/ Biotechnology based venture specialising in the manufacture of catalytic preparation, other organic compounds such as speciality organic molecules, biologically active peptides etc
, which are high-value products used in drug, agrochemical and speciality chemicals industries
The Company started operations at Unit I and set up a Custom Synthesis Plant with a capacity of 6 KL in year 2007
It commenced discovery biology services with a fermentation capacity of 2 KL in 2008
It expanded the Custom Synthesis Plant at Unit I increasing its capacity from 6 KL to 24 KL in 2010
It set up a high potent lab at Unit I - Bommasandra Facility in 2016
The Company was merged with Anthem Cellutions (India) Private Limited by acquiring 100% of its share capital in November, 2017
It set up a flow chemistry lab scale and solid phase peptide synthesis GMP lab with a capacity of 6 KL at Unit 1

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI59.85

SMA 20875.77

SMA 50814.36

SMA 100789.24

SMA 200721.24

SMA 10891.77

MACD_12_26_Days26.15

EMA10Day892.30

EMA20Day873.09

EMA50Day831.34

MACD_12_26_9_Days-0.65

EMA100Day793.95

EMA200Day763.93

Pivot Points

Volume Analysis

Delivery

Total Volume

Growth Rate

Revenue Growth15.17%

ROE21.71%

EBITDA Margin45.44%

All figures in ₹ Crores

Indicators	2026	2025	2024	2023	2022
Revenue	2,124.33	1,844.55	1,419.37	1,056.92	1,231.26
Interest	6.89	10.33	9.54	6.76	10.09
Expenses	1,290.52	1,173.72	914.39	628.04	666.25
Financing Profit	989.60	756.57	568.68	505.95	613.98
Financing Margin %	47%	41%	40%	48%	50%
Other Income	155.78	85.73	63.70	77.07	48.98
Depreciation	134.07	89.37	81.82	63.70	57.76
Profit before tax	824.24	656.87	477.32	497.30	546.14
Tax %	28%	31%	23%	23%	26%
Net Profit	591.79	451.26	367.31	385.19	405.54
EPS in Rs	10.55	8.07	6.48	6.75	467.55

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

Deal	Date	Type	Quantity	Price	Traded %
360 ONE MUTUAL FUND	18 Jun ‘26	Purchase	3,35,661	₹744.8	17.93%
KOTAK MAHINDRA LIFE INSURANCE COMPANY LIMITED	18 Jun ‘26	Purchase	1,07,460	₹744.8	5.74%
BAJAJ LIFE INSURANCE LIMITED	18 Jun ‘26	Purchase	12,08,379	₹744.8	64.56%
CANARA ROBECO MUTUAL FUND	18 Jun ‘26	Purchase	5,37,057	₹744.8	28.69%
EDELWEISS MUTUAL FUND	18 Jun ‘26	Purchase	3,35,661	₹744.8	17.93%
GHISALLO MASTER FUND LP	18 Jun ‘26	Purchase	3,35,661	₹744.8	17.93%
HDFC MUTUAL FUND	18 Jun ‘26	Purchase	13,42,643	₹744.8	71.73%
ICICI PRUDENTIAL LIFE INSURANCE COMPANY LIMITED	18 Jun ‘26	Purchase	12,08,379	₹744.8	64.56%
INTEGRATED CORE STRATEGIES ASIA PTE LTD	18 Jun ‘26	Purchase	2,000	₹744.8	0.11%
INTEGRATED CORE STRATEGIES ASIA PTE LTD	18 Jun ‘26	Purchase	8,000	₹744.8	0.43%

News

📊

No Information Available

No news available for this company.

Record Date

Corporate Action

Information

Announcement Day

22 Jul 2026

AGM

19 May 2026

26 Jun 2026

Final Dividend (₹2)

The Board recommended a final dividend of INR 2.00 per equity share of face value of INR 2.00 each for the Financial Year ended March 31, 2026, subject to the Shareholders approval at the ensuing Annual General Meeting of the Company. Accordingly, the said dividend, if approved, by the Shareholders at the ensuing Annual General Meeting of the Company, will be paid within 30 days from the date of Annual General Meeting, subject to deduction of tax at source.

19 May 2026

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
923	51,994	88	17	71	0	27.86%
1,930	4,63,180	37	6	30	0	19.78%
9,165	2,43,302	82	15	70	0	24.32%
4,959	1,88,623	85	22	50	1	11.09%
1,164	1,16,114	24	4	18	0	9.82%
1,418	1,14,554	32	3	24	0	9.92%
1,860	1,00,498	92	19	64	1	13.06%
2,150	98,312	17	4	13	0	19.16%
1,171	97,741	30	3	18	0	12.34%
2,360	97,467	46	6	32	0	13.57%

Showing 10 of 140 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in just 5 minutes*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

EPLEPL Ltd
₹240.35-21.71 (-8.28%)

Group Stocks

Adani Stocks

Tata Group Stocks

Frequently Asked Questions

What is Share Price of Anthem Biosciences Ltd?

The current share price of Anthem Biosciences Ltd (Anthem Bioscienc) is ₹924.50. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Anthem Biosciences Ltd?

The Price-to-Earnings (P/E) ratio of Anthem Biosciences Ltd is 924.50. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Anthem Biosciences Ltd?

Anthem Biosciences Ltd has a 52-week high of ₹942.60 and a 52-week low of ₹579.15. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Anthem Biosciences Ltd?

Anthem Biosciences Ltd offers a dividend yield of 0.22%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Anthem Biosciences Ltd?

The Earnings Per Share (EPS) of Anthem Biosciences Ltd is ₹10.53. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Anthem Biosciences Ltd?

Anthem Biosciences Ltd has a Return on Equity (ROE) of 23.70%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds. Play Video